| Literature DB >> 15494501 |
Galit Mishan-Eisenberg1, Zipora Borovsky, Matthew C Weber, Roi Gazit, Mark L Tykocinski, Jacob Rachmilewitz.
Abstract
The potency of TCR signaling during primary CD4+ T cell activation influences initial cytokine expression patterns and subsequent polarization toward either Th1 or Th2 subsets. In this study, we demonstrate that the T cell inhibitor placental protein 14 (PP14; glycodelin) preferentially inhibits Th1 cytokine responses and chemokine expression when present during ex vivo priming of CD4+ T cells. PP14 synergizes with exogenously added IL-4 in skewing T cell responses. Significantly, PP14 impairs the down-regulation of GATA-3 transcriptional regulator expression that normally accompanies T cell activation, which is a prerequisite for Th1 development. Taken together, these data document for the first time the ability of PP14 to skew Th responses.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15494501 DOI: 10.4049/jimmunol.173.9.5524
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422